US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 1.680
  • +0.040+2.44%
Close Sep 27 16:00 ET
  • 1.680
  • 0.0000.00%
Post 20:02 ET
329.66MMarket Cap-1976P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
186.33%73.83M
466.14%137.74M
54.14%116.33M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
-3.79%75.48M
22.19%18.82M
31.72%18.98M
Operating revenue
186.33%73.83M
466.14%137.74M
54.14%116.33M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
-3.79%75.48M
22.19%18.82M
31.72%18.98M
Cost of revenue
130.02%15.61M
-13.53%10.08M
60.44%43.27M
175.29%11.45M
105.61%13.38M
-26.05%6.79M
63.54%11.65M
89.68%26.97M
-18.03%4.16M
17.06%6.51M
Gross profit
206.45%58.23M
907.02%127.66M
50.63%73.07M
41.89%20.8M
65.08%20.59M
96.59%19M
8.25%12.68M
-24.48%48.51M
41.95%14.66M
40.93%12.47M
Operating expense
-0.73%55.65M
-9.61%55.39M
0.27%228.63M
10.48%63.17M
-11.04%48.13M
-9.64%56.06M
12.03%61.28M
-21.64%228.01M
-13.32%57.17M
-16.25%54.1M
Selling and administrative expenses
30.11%44.19M
40.42%41.99M
30.66%142.52M
88.18%45.42M
33.21%33.24M
14.69%33.96M
-1.58%29.9M
-41.03%109.08M
-37.04%24.14M
-36.45%24.95M
Research and development costs
-48.14%11.46M
-57.29%13.4M
-27.60%86.11M
-46.29%17.74M
-48.92%14.89M
-31.86%22.1M
29.04%31.38M
12.22%118.93M
19.62%33.03M
15.05%29.14M
Operating profit
106.96%2.58M
248.69%72.27M
13.34%-155.56M
0.34%-42.37M
33.85%-27.53M
29.25%-37.06M
-13.06%-48.61M
20.83%-179.5M
23.58%-42.51M
25.33%-41.62M
Net non-operating interest income expense
5.60%-13.72M
2.52%-14.02M
-3.81%-58.98M
-5.08%-15.06M
-5.95%-15M
-1.90%-14.54M
-2.31%-14.39M
-22.56%-56.81M
-6.69%-14.33M
-3.65%-14.15M
Non-operating interest expense
-5.60%13.72M
-2.52%14.02M
3.81%58.98M
5.08%15.06M
5.95%15M
1.90%14.54M
2.31%14.39M
22.56%56.81M
6.69%14.33M
3.65%14.15M
Other net income (expense)
-3,159.10%-50.78M
118.15%2.78M
99.51%5.29M
-20.30%1.08M
93.93%1.28M
422.01%1.66M
297.81%1.27M
-33.28%2.65M
-65.60%1.36M
4,969.23%659K
Special income (charges)
---53.24M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--53.24M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
47.83%2.45M
118.15%2.78M
99.51%5.29M
-20.30%1.08M
93.93%1.28M
422.01%1.66M
297.81%1.27M
-33.28%2.65M
-65.60%1.36M
4,969.23%659K
Income before tax
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
Income tax
Net income
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
Net income continuous Operations
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
Minority interest income
Net income attributable to the parent company
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
Basic earnings per share
28.26%-0.33
145.57%0.36
42.33%-2.03
34.21%-0.5
54.32%-0.37
56.19%-0.46
15.05%-0.79
62.19%-3.52
57.06%-0.76
69.08%-0.81
Diluted earnings per share
28.26%-0.33
143.04%0.34
42.33%-2.03
34.21%-0.5
54.32%-0.37
56.19%-0.46
15.05%-0.79
62.19%-3.52
57.06%-0.76
69.08%-0.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 186.33%73.83M466.14%137.74M54.14%116.33M71.38%32.25M78.97%33.97M36.86%25.79M29.16%24.33M-3.79%75.48M22.19%18.82M31.72%18.98M
Operating revenue 186.33%73.83M466.14%137.74M54.14%116.33M71.38%32.25M78.97%33.97M36.86%25.79M29.16%24.33M-3.79%75.48M22.19%18.82M31.72%18.98M
Cost of revenue 130.02%15.61M-13.53%10.08M60.44%43.27M175.29%11.45M105.61%13.38M-26.05%6.79M63.54%11.65M89.68%26.97M-18.03%4.16M17.06%6.51M
Gross profit 206.45%58.23M907.02%127.66M50.63%73.07M41.89%20.8M65.08%20.59M96.59%19M8.25%12.68M-24.48%48.51M41.95%14.66M40.93%12.47M
Operating expense -0.73%55.65M-9.61%55.39M0.27%228.63M10.48%63.17M-11.04%48.13M-9.64%56.06M12.03%61.28M-21.64%228.01M-13.32%57.17M-16.25%54.1M
Selling and administrative expenses 30.11%44.19M40.42%41.99M30.66%142.52M88.18%45.42M33.21%33.24M14.69%33.96M-1.58%29.9M-41.03%109.08M-37.04%24.14M-36.45%24.95M
Research and development costs -48.14%11.46M-57.29%13.4M-27.60%86.11M-46.29%17.74M-48.92%14.89M-31.86%22.1M29.04%31.38M12.22%118.93M19.62%33.03M15.05%29.14M
Operating profit 106.96%2.58M248.69%72.27M13.34%-155.56M0.34%-42.37M33.85%-27.53M29.25%-37.06M-13.06%-48.61M20.83%-179.5M23.58%-42.51M25.33%-41.62M
Net non-operating interest income expense 5.60%-13.72M2.52%-14.02M-3.81%-58.98M-5.08%-15.06M-5.95%-15M-1.90%-14.54M-2.31%-14.39M-22.56%-56.81M-6.69%-14.33M-3.65%-14.15M
Non-operating interest expense -5.60%13.72M-2.52%14.02M3.81%58.98M5.08%15.06M5.95%15M1.90%14.54M2.31%14.39M22.56%56.81M6.69%14.33M3.65%14.15M
Other net income (expense) -3,159.10%-50.78M118.15%2.78M99.51%5.29M-20.30%1.08M93.93%1.28M422.01%1.66M297.81%1.27M-33.28%2.65M-65.60%1.36M4,969.23%659K
Special income (charges) ---53.24M------------------0----------------
-Less:Other special charges --53.24M------------------------------------
Other non- operating income (expenses) 47.83%2.45M118.15%2.78M99.51%5.29M-20.30%1.08M93.93%1.28M422.01%1.66M297.81%1.27M-33.28%2.65M-65.60%1.36M4,969.23%659K
Income before tax -24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M
Income tax
Net income -24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M
Net income continuous Operations -24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M
Minority interest income
Net income attributable to the parent company -24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M
Basic earnings per share 28.26%-0.33145.57%0.3642.33%-2.0334.21%-0.554.32%-0.3756.19%-0.4615.05%-0.7962.19%-3.5257.06%-0.7669.08%-0.81
Diluted earnings per share 28.26%-0.33143.04%0.3442.33%-2.0334.21%-0.554.32%-0.3756.19%-0.4615.05%-0.7962.19%-3.5257.06%-0.7669.08%-0.81
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data